Related Experiment Videos

Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer

M J Millward¹, B M Cantwell, M Dowsett

¹University Department of Clinical Oncology, Newcastle General Hospital, Newcastle-Upon-Tyne, UK.

British Journal of Cancer

|May 1, 1991

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion.

British journal of cancer·2001

Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling.

Oncogene·2001

A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001

Hypoxia-inducible expression of tumor-associated carbonic anhydrases.

Cancer research·2001

Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines.

Cancer research·2001

The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.

Clinical cancer research : an official journal of the American Association for Cancer Research·2000

See all related articles